450 related articles for article (PubMed ID: 28468680)
1. CD3
Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure.
Cunha CF; Ferraz R; Pimentel MI; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
Parasite Immunol; 2016 Apr; 38(4):244-54. PubMed ID: 26928901
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
Ferraz R; Cunha CF; Gomes-Silva A; Schubach AO; Pimentel MI; Lyra MR; Mendonça SC; Valete-Rosalino CM; Da-Cruz AM; Bertho ÁL
BMC Infect Dis; 2015 Feb; 15():74. PubMed ID: 25870976
[TBL] [Abstract][Full Text] [Related]
5. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8
Covre LP; Devine OP; Garcia de Moura R; Vukmanovic-Stejic M; Dietze R; Ribeiro-Rodrigues R; Guedes HLM; Lubiana Zanotti R; Falqueto A; Akbar AN; Gomes DCO
Immunology; 2020 Apr; 159(4):429-440. PubMed ID: 31925782
[TBL] [Abstract][Full Text] [Related]
6. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.
Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI
J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919
[TBL] [Abstract][Full Text] [Related]
8. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions.
Da-Cruz AM; Bertho AL; Oliveira-Neto MP; Coutinho SG
Br J Dermatol; 2005 Sep; 153(3):537-43. PubMed ID: 16120139
[TBL] [Abstract][Full Text] [Related]
11. The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.
Mendes-Aguiar Cde O; Gomes-Silva A; Nunes E; Pereira-Carvalho R; Nogueira RS; Oliveira-Neto Mde P; Bertho AL; Da-Cruz AM
Clin Exp Immunol; 2009 Sep; 157(3):377-84. PubMed ID: 19664146
[TBL] [Abstract][Full Text] [Related]
12. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
13. Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.
de Oliveira Mendes-Aguiar C; Vieira-Gonçalves R; Guimarães LH; de Oliveira-Neto MP; Carvalho EM; Da-Cruz AM
Clin Exp Immunol; 2016 Aug; 185(2):202-9. PubMed ID: 27059407
[TBL] [Abstract][Full Text] [Related]
14. Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.
Pereira-Carvalho R; Mendes-Aguiar CO; Oliveira-Neto MP; Covas CJ; Bertho AL; Da-Cruz AM; Gomes-Silva A
PLoS One; 2013; 8(11):e81529. PubMed ID: 24303052
[TBL] [Abstract][Full Text] [Related]
15. CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.
Keesen TS; Antonelli LR; Faria DR; Guimarães LH; Bacellar O; Carvalho EM; Dutra WO; Gollob KJ
Clin Exp Immunol; 2011 Sep; 165(3):338-51. PubMed ID: 21726211
[TBL] [Abstract][Full Text] [Related]
16. T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.
Da-Cruz AM; Oliveira-Neto MP; Bertho AL; Mendes-Aguiar CO; Coutinho SG
J Invest Dermatol; 2010 May; 130(5):1329-36. PubMed ID: 20107484
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
18. Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
Carvalho AM; Guimarães LH; Costa R; Saldanha MG; Prates I; Carvalho LP; Arruda S; Carvalho EM
J Infect Dis; 2021 Feb; 223(3):527-535. PubMed ID: 32620011
[TBL] [Abstract][Full Text] [Related]
19.
Scorpio DG; Choi KS; Dumler JS
Front Immunol; 2018; 9():710. PubMed ID: 29686681
[TBL] [Abstract][Full Text] [Related]
20. Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease.
Brelaz MC; de Oliveira AP; de Almeida AF; de Assis Souza M; Medeiros ÂC; de Brito ME; Pereira VR
Parasite Immunol; 2012 Apr; 34(4):236-9. PubMed ID: 22394223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
